Tag - pharmaceuticals

 
Menu
Search
 
May 17, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

PHARMACEUTICALS

Japan Times
BUSINESS / Companies
Mar 31, 2020
Firms sign deals with U.S. to prep for mass-producing virus vaccines
The U.S. government has cut deals with Johnson & Johnson and Moderna Inc. and said it is in talks with at least two other companies to prepare them to produce massive quantities of coronavirus vaccines even before safe and effective ones become available.
JAPAN / Science & Health
Mar 24, 2020
Japan to join trial to test Ebola drug on COVID-19 patients
The National Center for Global Health and Medicine (NCGM) said Monday that it will join an international clinical trial on the use of remdesivir, which is being developed as a remedy for Ebola, to treat people infected with the new coronavirus.
Japan Times
JAPAN / Science & Health
Mar 19, 2020
Japanese researchers to test blood thinner for coronavirus treatment
A blood thinner used to treat pancreatitis and kidney disease has been identified as a potential therapy for COVID-19 patients, with clinical trials in Japan possibly set to begin within a month, researchers at the University of Tokyo said Wednesday.
Japan Times
WORLD / Science & Health
Mar 19, 2020
HIV drug combo fails as treatment for severe COVID-19 in China study
A pill containing two HIV drugs that was touted as a potential treatment for the novel coronavirus was not effective, according to a study released late on Wednesday in the New England Journal of Medicine.
Japan Times
BUSINESS
Mar 4, 2020
Japan's largest drugmaker working to develop virus treatment, Dow Jones reports
Takeda Pharmaceutical Co. is developing an experimental therapy for the novel coronavirus with the goal of making it available in 9 to 18 months, the nation's largest drugmaker said.
Japan Times
JAPAN / Science & Health
Feb 26, 2020
Japanese government panel OKs expensive gene therapy for rare disease
A health ministry panel approved the production and sales of a gene therapy for treating spinal muscular atrophy, a rare incurable disease that destroys muscle function.
BUSINESS
Feb 26, 2020
U.S. begins first coronavirus clinical trial testing Gilead's experimental drug
U.S. health officials said on Tuesday the first clinical trial testing Gilead Sciences Inc.'s experimental antiviral drug, remdesivir, in hospitalized patients with the coronavirus has started.
Japan Times
BUSINESS
Feb 24, 2020
Boris Johnson to begin trade talks with U.S. in two weeks, Telegraph reports
British Prime Minister Boris Johnson is prepared to begin trade talks with the United States within the coming two weeks, the Telegraph reported on Sunday.
JAPAN / Science & Health
Feb 22, 2020
Tosoh working on chemical reagent that could slash COVID-19 detection times
Chemical maker Tosoh Corp. said it has begun developing a reagent that can detect the new coronavirus in less than 50 minutes, slashing the six-hour waiting time required by current test kits.
JAPAN / Science & Health
Feb 22, 2020
Japan might approve anti-flu drug Avigan to treat coronavirus patients
Japan is considering using Avigan, an influenza medication developed by a unit of Fujifilm Holdings Corp., to treat patients of the novel coronavirus, health minister Katsunobu Kato says.
Japan Times
BUSINESS / Companies
Feb 20, 2020
As COVID-19 spreads, Takeda CEO urges more industry investment in vaccines
The spread of novel coronavirus infections is starting to make one thing clear: More vaccine investment is needed, the CEO of Asia's biggest drugmaker said.
Japan Times
WORLD / Science & Health
Feb 19, 2020
In fighting outbreaks like COVID-19, Big Pharma struggles to get out front
Sanofi has joined the race to combat coronavirus as the outbreak is kindling fears of a pandemic. The question is whether its effort will prove more effective than some of Big Pharma's past attempts to tackle dangerous new pathogens.
Japan Times
ASIA PACIFIC / Science & Health
Feb 18, 2020
Lung biopsy of deceased China patient shows SARS-like damage
Doctors studying a 50-year-old man who died in China last month from the new coronavirus found that the disease caused lung damage reminiscent of two prior coronavirus-related outbreaks, SARS and MERS.
Japan Times
ASIA PACIFIC / Science & Health
Feb 14, 2020
Gilead drug prevents type of coronavirus in monkeys, raising hope for China trials
An experimental Gilead Sciences antiviral drug prevented disease and reduced the severity of symptoms in monkeys infected with Middle East respiratory syndrome (MERS), an infection closely related to the fast-spreading coronavirus that originated in China, a study published on Thursday found.
Japan Times
ASIA PACIFIC / Science & Health
Feb 13, 2020
Results from Chinese drug trials for coronavirus due in weeks: expert
Chinese scientists are testing two antiviral drugs against the new coronavirus and preliminary clinical trial results are weeks away, the co-chair of a World Health Organization (WHO) meeting said on Wednesday.
Japan Times
ASIA PACIFIC / Science & Health
Feb 6, 2020
Drugmakers see long road ahead in coronavirus vaccine race
Drugmakers racing to find a vaccine or effective treatment for the deadly new coronavirus cautioned that they have a long way to go.
Japan Times
BUSINESS
Jul 12, 2019
White House scraps key plan to lower U.S. drug prices, may target makers
The Trump administration on Thursday scrapped one of its most ambitious proposals for lowering prescription medicine prices, backing down from a policy aimed at health insurers and raising the possibility of new measures focused on drug makers.
Japan Times
WORLD / Science & Health
Jun 20, 2019
Eroding trust in vaccines leaves populations vulnerable, global study finds
Trust in vaccines — one of the world's most effective and widely-used medical products — is highest in poorer countries but weaker in wealthier ones where skepticism has allowed outbreaks of diseases such as measles to persist, a global study released Wednesday has found.
WORLD / Science & Health
May 16, 2019
Scientists launch push to beat cancer's ability to adapt against treatments
Cancer scientists in Britain are launching what they call the world's first "Darwinian" drug development program in a bid to get ahead of cancer's ability to become resistant to even the newest treatments and recur in many patients.
Japan Times
BUSINESS / Companies
Mar 29, 2019
AstraZeneca bets $6.9 billion that Daiichi Sankyo therapy will transform cancer treatment
Britain's AstraZeneca's biggest deal in recent memory give it access to the Japanese drugmaker's promising but difficult to pronounce cancer treatment: trastuzumab deruxtecan.
Japanese stripper bids to have her porn movies taken off internet
Plaintiff Miyuki Ariga (left) speaks at a news conference along with her lawyer, Yoshitomo Morohashi, after filing a lawsuit at the Tokyo District Court on Monday.
Kishida defends planned rule to revoke foreigners' residency
Prime Minister Fumio Kishida speaks during a meeting of the Lower House Judicial Affairs Committee on Wednesday.
Human bone-like objects found at Nippon Steel plant’s molten iron pot, with one worker missing
Police believe it’s highly possible that human bones found in a molten iron pot at Nippon Steel's Oita factory belong to a missing male employee.
Was Onosato's defeat of Terunofuji an era-defining bout?
Onosato (right) defeats Terunofuji at the Ryogoku Kokugikan in Tokyo on May 12. While nothing in sumo is guaranteed, it seems almost inevitable that Onosato is destined for the top of the sport's pyramid.
Man suspected of using smart glasses to cheat on Waseda University exams
The Waseda University campus in Tokyo. An 18-year-old male test-taker is suspected of using smart glasses to cheat during the university's entrance exam.
Japanese billionaire sues Meta over investment scams using his image
Entrepreneurs Yusaku Maezawa (second from right) and Takafumi Horie (third from right) attend a study session on fake social media ads and investment scams at the Liberal Democratic Party headquarters in Tokyo on April 10.
Japanese rap creates its mecca in Pop Yours
Tokyo-based artist Jumadiba says he forgoes the label of simply “rap” for his music because the Japanese rap scene isn’t confined to a particular sound.
Who’s toughest on China? Biden’s tariff tactic ups ante as election looms.
U.S. President Joe Biden speaks about new actions to protect American workers and businesses from China's "unfair" trade practices, in the Rose Garden of the White House in Washington on Tuesday.
Was Onosato's defeat of Terunofuji an era-defining bout?
Onosato (right) defeats Terunofuji at the Ryogoku Kokugikan in Tokyo on May 12. While nothing in sumo is guaranteed, it seems almost inevitable that Onosato is destined for the top of the sport's pyramid.
Ishin struggles to set itself apart from other parties
Nippon Ishin no Kai Secretary-General Fumitake Fujita (right) speaks beside Yui Kanazawa, the party's candidate in the Tokyo 15th district by-election on April 28. Nippon Ishin lost in this by-election as well as another in Nagasaki held on the same day.

Podcast

From easily navigable train stations to the helpfulness of its municipal staff, Tokyo has earned high praise for its commitment to accessibility for disabled travelers.
[Rebroadcast] Japan is doing better on accessibility than you may think

Longform

Things may look perfect to the outside world, but today's mom is fine with some imperfection at home.
How 'Reiwa moms' are reshaping motherhood in Japan
By Mai Yoshikawa

SUSTAINABLE JAPAN

Vol. 35: Travel in time — and stay there
Vol. 35: Travel in time — and stay there

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER